Natural Products & Phytotherapeutics: why a new section?

Authors

  • Marcello Iriti Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan - Italy https://orcid.org/0000-0002-5063-1236

DOI:

https://doi.org/10.33393/dti.2023.2548

Abstract

-

Downloads

Download data is not yet available.

References

Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770-803. https://doi.org/10.1021/acs.jnatprod.9b01285 PMID:32162523 DOI: https://doi.org/10.1021/acs.jnatprod.9b01285

Iriti M. Journal of Phytomoleculs & Pharmacology:‘Why a new journal?’ J Phytomol Pharmacol. 2022;1(1):1-2. https://leafletpub.com/article-detail/12 DOI: https://doi.org/10.56717/jpp.2022.v01i01.001

WHO Global Report on Traditional and Complementary Medicine 2019. World Health Organization; 2019. https://apps.who.int/iris/handle/10665/312342. Accessed December 2022.

Peluso I. Phytomolecules-drug interactions: clinical and nutritional implications. J Phytomol Pharmacol. 2022;1(2):56-57. https://doi.org/10.56717/jpp.2022.v01i02.008 DOI: https://doi.org/10.56717/jpp.2022.v01i02.008

Varoni EM, Lodi G, Iriti M. Efficacy behind activity – phytotherapeutics are not different from pharmaceuticals. Pharm Biol. 2015;53(3):404-406. https://doi.org/10.3109/13880209.2014.923000 PMID:25472494 DOI: https://doi.org/10.3109/13880209.2014.923000

Downloads

Published

2023-01-16

How to Cite

Iriti, M. (2023). Natural Products & Phytotherapeutics: why a new section?. Drug Target Insights, 17(1), 1–4. https://doi.org/10.33393/dti.2023.2548

Issue

Vol. 17 No. 1 (2023): January-December 2023

Section

Editorial

Categories

License

Copyright (c) 2023 The Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Received 2022-12-12
Accepted 2022-12-15
Published 2023-01-16

Metrics

Crossref
Scopus
Google Scholar
Europe PMC